TVGNW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNW
Should you be buying Tevogen Bio stock or one of its competitors? The main competitors of Tevogen Bio include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry.
Tevogen Bio vs. Its Competitors
180 Life Sciences (NASDAQ:ATNFW) and Tevogen Bio (NASDAQ:TVGNW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.
In the previous week, 180 Life Sciences had 1 more articles in the media than Tevogen Bio. MarketBeat recorded 4 mentions for 180 Life Sciences and 3 mentions for Tevogen Bio. Tevogen Bio's average media sentiment score of 1.95 beat 180 Life Sciences' score of 1.54 indicating that Tevogen Bio is being referred to more favorably in the news media.
Summary
180 Life Sciences and Tevogen Bio tied by winning 1 of the 2 factors compared between the two stocks.
Get Tevogen Bio News Delivered to You Automatically
Sign up to receive the latest news and ratings for TVGNW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TVGNW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
TVGNW vs. The Competition
Tevogen Bio Competitors List
Related Companies and Tools
This page (NASDAQ:TVGNW) was last updated on 8/13/2025 by MarketBeat.com Staff